account�� Multibillion dollar revenue producers go off patent protection with nothing new waiting in the wings.�� Merck, Eli Lilly, Pfizer and Bristol-Myers Squibb now are yield stocks with just some promise of financial engineering like stock buybacks and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Open Season On Icons, From Apple To Charlie Sheen
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account